EndoPure Life Sciences

EndoPure Life Sciences is a UK-based biopharmaceutical company specializing in the development of high-purity, plant-derived cannabinoid medicines. The company utilizes advanced extraction and purification technologies to produce pharmaceutical-grade active pharmaceutical ingredients (APIs) that meet stringent regulatory standards. Their primary focus is on creating consistent, dose-accurate formulations for therapeutic areas including neurology and pain management. EndoPure's pipeline includes programs targeting epilepsy and chronic inflammatory conditions, aiming to bridge the gap between botanical extracts and standardized pharmaceutical products. By combining botanical expertise with rigorous pharmaceutical science, the company seeks to provide reliable alternatives to synthetic and less-refined cannabinoid treatments.